Skip to main content
Top

Cancer Causes & Control

Issue 5/2001

Content (11 Articles)

Reduced sun exposure and tanning in children after 2 years of a school-based intervention (Australia)

Elizabeth Milne, Dallas R. English, Robyn Johnston, Donna Cross, Ron Borland, Billie Giles-Corti, Christine Costa

Organochlorines and breast cancer risk by receptor status, tumor size, and grade (Canada)

Christy G. Woolcott, Kristan J. Aronson, Wedad M. Hanna, Sandip K. SenGupta, David R. McCready, Ernest E. Sterns, Anthony B. Miller

Colorectal cancer following tamoxifen therapy for breast cancer (United States)

Linda S. Cook, Noel S. Weiss, Nikolas Pharris-Ciurej, Stephen M. Schwartz, Emily White

The contribution of cigarette smoking to bladder cancer in women (pooled European data)

Paul Brennan, Olivier Bogillot, Eberhard Greiser, Jenny Chang-Claude, Jürgen Wahrendorf, Sylvaine Cordier, Karl-Heinz Jöckel, Gonzalo Lopez-Abente, Anastasia Tzonou, Paolo Vineis, Francesco Donato, Martine Hours, Consol Serra, Ulrich Bolm-Audorff, Walter Schill, Manolis Kogevinas, Paolo Boffetta

Mouthwash in the etiology of oral cancer in Puerto Rico

Deborah M. Winn, Scott R. Diehl, Linda M. Brown, Lea C. Harty, Eleuterio Bravo-Otero, Joseph F. Fraumeni Jr., Dushanka V. Kleinman, Richard B. Hayes

Patterns and predictors of the breast cancer detection methods in women under 45 years of age (United States)

Ralph J. Coates, Robert J. Uhler, Donna J. Brogan, Marilie D. Gammon, Kathleen E. Malone, Christine A. Swanson, Elaine W. Flagg, Louise A. Brinton

Occupational risk factors, ultraviolet radiation, and ocular melanoma: a case–control study in France

Pascal Guénel, Laurent Laforest, Diane Cyr, Joëlle Févotte, Svend Sabroe, Cécile Dufour, Jean-Michel Lutz, Elsebeth Lynge

A review of physical activity and prostate cancer risk

Christine M. Friedenreich, Inger Thune

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine